SSPN and neoplasm: These ICD, DC maturation, and cytokine release profiles confirmed that SPNpro-, SPN-1-, and SPN-2-mediated therapy enhanced tumor immunogenicity to a similar level, which should be ascribed to their similar phototherapeutic efficiency.